Physician profile
Kevin Lim
NPI 1386990505
$43,421.08
in general payments reported to CMS, 2019-2025
8 companies · $8,316 in 2025
The $8,316 reported for 2025 was more than what 94% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,017 · 2020: $476 · 2021: $2,154 · 2022: $10K · 2023: $4,538 · 2024: $16K · 2025: $8,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $20K · Travel and Lodging: $7,500 · Food and Beverage: $1,302 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $19,600.00 |
| Travel and Lodging | $7,500.00 |
| Food and Beverage | $1,302.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $42,835.03 | 2019-2025 | |
| Dentsply Sirona INC | $161.71 | 2019-2024 | Astra Tech Implant System |
| Dentsply Ih INC. | $116.22 | 2019 | |
| Zimmer Biomet Holdings, INC. | $114.63 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $110.29 | 2019 | |
| Align Technology, INC. | $38.71 | 2020-2025 | Invisalign |
| Zimvie INC. | $29.90 | 2024 | |
| Philips North America LLC | $14.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.